<verdict>MOSTLY REALISTIC</verdict>
<score>7</score>
<lean>BALANCED</lean>
<lean_reasoning>
Most odds were sensible and failures were played as failures, so the month is close to balanced overall, but two outcomes pulled in opposite directions. Action 2 was played harsher than the simulator's own stated median. The CFO refused even the 0.5%/4-week fallback, and the simulator invented an unfunded training/holdout separation. Action 5 ran somewhat lenient: about 210 self-reporting hospitals and 3,100 stars within roughly two weeks of release.
</lean_reasoning>
<reasoning>
**Odds.** Most were well grounded in the established institutional history.
- Action 1 at 35% matched a willing Chief Scientist and a cheap Option B.
- Action 3 at 72% was right: AISI cannot build and adjudicate a reference harness within weeks.
- Action 4 at 70% matched counsel's repeated quiet-period refusals.
- The threats were priced sensibly. Threat 1 at 6% and Threat 2 at 10% fit the grid's hardening and the multi-site Stargate build. The Lithuania SCADA trace honoured the non-materialisation without forcing anything.

**Successes were properly watered down.** Action 1 got a 6% floor, not 8%. The 10% share was dropped, and the auto-pause became a CEO decision within 5 business days. That is a realistic margin-15 result.

**Action 2 was played too harshly.** The simulator stated that "a cut to 4 weeks or 0.5% is the modal outcome." At a roll of 50, the median result should have been that cut. Instead it narrated a full refusal of both the main ask and the fallback. It then added a new consequence the player never risked: the Option B environments are charged to CI-6 training compute, which leaves the holdout separation with no budget line.

**Action 5 was played too generously.** The kit was released on 15 July. By month-end, about 210 hospitals self-report running it, from a single clinic of 64 attendees, and the repo has 3,100 stars. That is generous for a niche healthcare security tool in roughly two weeks. Direct scans at 129 are on trend.

**Action 6, exogenous events and capability.**
- Action 6 at 45% (margin 5) produced a narrow mixed result, which is appropriate. The GFI miss and a single Durban enrolment are on trend.
- The exogenous events (OpenAI's filing with a self-published card, Kimi K5, Heartland's missed coupon) are plausible and roughly neutral.
- Capability rose +0.09 internally, within the stated band. However, 1.69 CI points remain over 17 months, so the required pace is about 0.10 per month. The simulator did not show required versus projected pace.
</reasoning>
<issues>
- **Action 2 was resolved below its own stated median.** The simulator said a cut to 4 weeks or 0.5% was modal, then narrated a refusal of the fallback as well. That is a tail outcome presented as the median.
- **Invented friction in Action 2.** Charging the Option B environments to CI-6 training compute, so the holdout separation is unfunded, was not a named risk of the action.
- **Action 5 adoption is too fast.** About 210 self-reporting hospitals and 3,100 stars within about 16 days of release, from one clinic, is generous. Something nearer 60–100 hospitals would be more plausible.
- **No explicit capability-pace check.** Internal CI-5.31 needs about +0.10 per month to reach CI-7.0 by December 2030. The stated band of +0.08 to +0.12 is borderline, and CI-6's expected jump was not quantified.
- **Minor gap in reactions.** Competitor labs did not respond to the CI-5 GA beyond OpenAI's filing, which was presumably already scheduled. There was also no GDM reaction.
</issues>
<feedback_for_simulator>
- When you state a modal outcome for a failed action in message 1, resolve to that outcome at a roll of 50. Do not drop to a worse tail. Do not add consequences that were not among the named risks.
- Ground adoption numbers in channel capacity. Count clinic attendees, association membership and organic GitHub growth for comparable tools, and avoid round numbers that jump ahead of the channels.
- Each month, report the required versus projected internal pace to CI-7.0, and quantify the expected CI-6 step when training starts in September.
- When the CFO revisits the allocation in August, price it on the real August load data, and keep the earlier pattern of trims rather than all-or-nothing outcomes.
</feedback_for_simulator>

<du_progress>
A. Verified technical alignment: 3/10 (0). Evidence: CI-6 design v1.0 now has a 6% honesty/omission RL-environment floor with audited graders, plus milestone readings. Against that, the reading of record is still 1.13× on a pool that is now stale, the honeypot-recognition check never ran, and AISI's Q2 summary is aggregate only ("low but non-zero omission").

B. Real-world alignment in action: 5/10 (0). Evidence: the RSO filed a staleness caveat with AISI, which is an honest disclosure of weaker measurement. Comms reduced the external-evaluation invitation to boilerplate, and the cost memo is held.

C. Human alignment: 2/10 (0). Evidence: public trust in AI is 7. CI-5 coverage centres on displacement. OpenAI and Apollo are still publicly disputing, and there is no coordination between labs.

D. Self-repairing systems: 5/10 (−1). Evidence: the integrity allocation lapsed, so the rotating fresh pool that caught overfit can no longer rotate, and CI-6 milestone readings will reuse items. The CI-6 stop rule was softened to a CEO decision. The forcing-package tier was lowered, a small positive.

E. Capability growth without trouble: 1/10 (0). Evidence: Kimi K5 adds open-weight autonomous reconnaissance. No new major incident occurred, and the Lithuania anomaly was benign. CI-5 shipped broadly, and pace is borderline for CI-7.

F. Robust governance and verification: 3/10 (0). Evidence: Commerce will fund spot-checks only "as appropriations allow." AISI declined the reference harness and deferred the comparison table. OpenAI's model is moving through an unfunded 21-day window.

G. Broad benefit and no permanent underclass: 2/10 (0). Evidence: the hospital self-scan kit is spreading, Career Transition reached 47.5k users, and the DNDi formulation is promising in silico only. GFI is at $269/g and unemployment at 6.9%.

H. Diversity, agency and consent: 4/10 (0). Evidence: power remains plural across labs. CI-6 safety stops now run through a CEO decision, and the override stays board-only.

Overall: 32/100 (−1)

Trajectory: FLAT.
- **Biggest gain:** the first alignment content (a 6% honesty-environment floor) entered the CI-6 design before the freeze.
- **Biggest backslide:** the lapsed integrity allocation leaves CI-6 milestone gating on a stale, non-rotating pool, with no automatic pause.
</du_progress>

<setup_fix>
none
</setup_fix>
